U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
RAGIFILIMAB
USAN   INN  
Official Name English
INCAGN-01876
Preferred Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TNFRSF18 (TUMOR NECROSIS FACTOR RECEPTOR (TNFR) SUPERFAMILY MEMBER 18, ACTIVATION-INDUCIBLE TNFR FAMILY RECEPTOR, AITR, GLUCOCORTICOID-INDUCED TNFR-RELATED, GITR, CD375)), HUMANIZED MONOCLONAL ANTIBODY; GAMMA1
Common Name English
IMMUNOGLOBULIN G1 (DE-448-LYSINE), ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR TNFRSF18) (HUMAN-MUS MUSCULUS MONOCLONAL INCAGN01876.GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL INCAGN01876 .KAPPA.-CHAIN, DIMER
Common Name English
ANTI-GITR AGONISTIC MONOCLONAL ANTIBODY INCAGN01876
Common Name English
CM701
Code English
ragifilimab [INN]
Common Name English
AGEN-1876
Code English
AGEN1876
Code English
CM-701
Code English
INCAGN01876
Code English
RAGIFILIMAB [USAN]
Common Name English
Ragifilimab [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C129822
Created by admin on Wed Apr 02 01:07:07 GMT 2025 , Edited by admin on Wed Apr 02 01:07:07 GMT 2025
NCI_THESAURUS C128058
Created by admin on Wed Apr 02 01:07:07 GMT 2025 , Edited by admin on Wed Apr 02 01:07:07 GMT 2025
Code System Code Type Description
SMS_ID
300000024159
Created by admin on Wed Apr 02 01:07:07 GMT 2025 , Edited by admin on Wed Apr 02 01:07:07 GMT 2025
PRIMARY
NCI_THESAURUS
C126643
Created by admin on Wed Apr 02 01:07:07 GMT 2025 , Edited by admin on Wed Apr 02 01:07:07 GMT 2025
PRIMARY
CAS
2207590-51-8
Created by admin on Wed Apr 02 01:07:07 GMT 2025 , Edited by admin on Wed Apr 02 01:07:07 GMT 2025
PRIMARY
INN
11280
Created by admin on Wed Apr 02 01:07:07 GMT 2025 , Edited by admin on Wed Apr 02 01:07:07 GMT 2025
PRIMARY
FDA UNII
O440IW9NHN
Created by admin on Wed Apr 02 01:07:07 GMT 2025 , Edited by admin on Wed Apr 02 01:07:07 GMT 2025
PRIMARY
USAN
JK-153
Created by admin on Wed Apr 02 01:07:07 GMT 2025 , Edited by admin on Wed Apr 02 01:07:07 GMT 2025
PRIMARY
ACTIVE MOIETY
RAGIFILIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966